Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis.

We have developed a real-time quantitative PCR assay to measure the concentration of fetal DNA in maternal plasma and serum. Our results show that fetal DNA is present in high concentrations in maternal plasma, reaching a mean of 25.4 genome equivalents/ml (range 3.3-69. 4) in early pregnancy and 292.2 genome equivalents/ml (range 76. 9-769) in late pregnancy. These concentrations correspond to 3.4% (range 0.39%-11.9%) and 6.2% (range 2.33%-11.4%) of the total plasma DNA in early and late pregnancy, respectively. Sequential follow-up study of women who conceived by in vitro fertilization shows that fetal DNA can be detected in maternal serum as early as the 7th wk of gestation and that it then increases in concentration as pregnancy progresses. These data suggest that fetal DNA can be readily detected in maternal plasma and serum and may be a valuable source of material for noninvasive prenatal diagnosis.

[1]  H. Nakauchi,et al.  The Proportion of Fetal Nucleated Red Blood Cells in Maternal Blood: Stimation by FACS Analysis , 1997, Prenatal diagnosis.

[2]  K. Fleming,et al.  PRENATAL SEX DETERMINATION BY DNA AMPLIFICATION FROM MATERNAL PERIPHERAL BLOOD , 1989, The Lancet.

[3]  John A. Todd,et al.  Towards fully automated genome–wide polymorphism screening , 1995, Nature Genetics.

[4]  V. Vasioukhin,et al.  K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. , 1997, Gastroenterology.

[5]  G. Weil,et al.  Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[6]  K. Klinger,et al.  Fetal cells in maternal blood: determination of purity and yield by quantitative polymerase chain reaction. , 1994, American journal of obstetrics and gynecology.

[7]  R. Abramson,et al.  Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[8]  I. Sargent,et al.  Presence of fetal DNA in maternal plasma and serum , 1997, The Lancet.

[9]  Y. Kan,et al.  Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood , 1996, Nature Genetics.

[10]  I. Sargent,et al.  Two-way cell traffic between mother and fetus: biologic and clinical implications. , 1996, Blood.

[11]  Boland Cr Setting microsatellites free. , 1996 .

[12]  David Sidransky,et al.  Microsatellite alterations in serum DNA of head and neck cancer patients , 1996, Nature Medicine.

[13]  J. Hartley,et al.  Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. , 1990, Gene.

[14]  F. Conte,et al.  Practical and theoretical implications of fetal-maternal lymphocyte transfer. , 1969, Lancet.

[15]  S. Latt,et al.  Isolation of fetal DNA from nucleated erythrocytes in maternal blood. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Rimm,et al.  Transplant or chemotherapy in acute myelogenous leukaemia , 1989 .

[17]  S. Kwok,et al.  Avoiding false positives with PCR , 1989, Nature.

[18]  A. Kurt,et al.  Microsatellite alterations in plasma DNA of small cell lung cancer patients , 1996, Nature Medicine.

[19]  I. Mackenzie,et al.  Prenatal determination of fetal RhD status by analysis of peripheral blood of rhesus negative mothers , 1993, The Lancet.

[20]  C. R. Connell,et al.  Allelic discrimination by nick-translation PCR with fluorogenic probes. , 1993, Nucleic acids research.

[21]  M. Sharf,et al.  Fetal obstructive uropathy [corrected]. , 1988, Lancet.

[22]  K. Livak,et al.  Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. , 1995, PCR methods and applications.

[23]  K. Klinger,et al.  PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. , 1997, American journal of human genetics.

[24]  Y. Lo,et al.  Strategies for the Detection of Autosomal Fetal DNA Sequence from Maternal Peripheral Blood , 1994, Annals of the New York Academy of Sciences.

[25]  G. Saglio,et al.  Prenatal diagnosis of fetal hemoglobin Lepore-Boston disease on maternal peripheral blood. , 1990, Blood.

[26]  J. Simpson,et al.  Isolating fetal cells from maternal blood. Advances in prenatal diagnosis through molecular technology. , 1993, JAMA.